SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that it has completed a series of strategic financial transactions, further strengthening its balance sheet and extending ...

Omeros Corporation (NASDAQ:OMER) is one of the hot stocks to buy with huge upside potential. On October 15, H.C. Wainwright raised the firm’s price target on Omeros to $20 from $9 and kept a Buy ...

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today reported that clinical trial site activation for enrollment is underway for the company’s Phase 3 program evaluating zaltenibart in ...

– Expanded deal brings Omeros $115 million upfront payment and opportunity for additional $55 million in sales-based milestones – SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today ...

– OMIDRIA®-Related Payment Expected to Provide Operating Capital into at Least 2025 – Omeros intends to use the proceeds received from Rayner, together with its existing cash as well as cash ...

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) (“Omeros” or the “Company”) today announced that it has entered into exchange agreements (the “Exchange Agreements”) with a limited number of ...

Shares of Omeros Corporation (NASDAQ: OMER), a rising star in the biotech industry, are losing altitude after the company reported first-quarter earnings today. The stock was down 16% earlier this ...

The MarketWatch News Department was not involved in the creation of this content. Interest expense during the first quarter of 2025 was $3.7 million compared to $8.2 million during the prior year ...

For online access to the live webcast of the conference call, go to Omeros’ website at https://investor.omeros.com/upcoming-events. To access the live conference ...